MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2018 International Congress

    Genome-wide association studies of motor and cognitive progression in Parkinson’s disease

    M. Tan, L. Hubbard, M. Lawton, S. Kanavou, N. Wood, J. Hardy, Y. Ben-Shlomo, N. Williams, D. Grosset, H. Morris (London, United Kingdom)

    Objective: Motor and cognitive progression in Parkinson’s is heterogeneous. Our aim is to identify single nucleotide polymorphisms (SNPs) associated with disease progression. Background: Rare genetic…
  • 2018 International Congress

    Microstructural Abnormalities in Drug-naïve Parkinson’s Disease with Mild Cognitive Impairment: A Diffusion Tensor Imaging Study

    N. Li, L. Wang, X. Suo, Z. Lu, J. Li, J. Peng, Q. Gong, R. Peng (Chengdu, Sichuan Province, China)

    Objective: The aim of this study was to use MR diffusion tensor imaging to investigate the brain microstructural alterations in newly diagnosed drug-naïve Parkinson’s disease…
  • 2018 International Congress

    Comparison of Volumetric MRI measurements between Dementia with Lewy bodies and prodromal Lewy body disease

    B. Tousi, F. Flanigan, k. Khosravi (Cleveland, OH, USA)

    Objective: To compare the volumetric changes between patients at prodromal stage of Lewy body disese and individuals with dementia with Lewy Bodies. Background: Volumetric magnetic…
  • 2018 International Congress

    The distinct cognitive syndromes of Huntington’s disease: A two-year follow-up study

    S. Martinez-Horta, F. Sampedro, A. Horta-Barba, J. Perez-Perez, J. Pagonabarraga, J. Marin-Lahoz, H. Bejr-Kasem, I. Aracil, MA. Boti, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore if patients can be clustered into different groups based on dissimilar patterns of cognitive deterioration in a 2-year follow-up; to study the…
  • 2018 International Congress

    Transcranial magnetic stimulation increases cognition globally and longitudinally in Parkinson’s disease

    J. Trung, A. Hanganu, S. Jobert, C. Degroot, B. Mejia-Constain, M.A. Bruneau, A.L. Lafontaine, Q.P.N. Clinicians, A. Strafella, O. Monchi (Montréal, QC, Canada)

    Objective: Using intermittent “theta burst” transcranial magnetic stimulation (iTBS) over the left dorsolateral prefrontal cortex (DLPFC) to assess the potential of long-term improvements in cognitive…
  • 2018 International Congress

    Using Vision to Predict Dementia in Parkinson’s Disease

    L-A. Leyland, R. Mahmood, S. Hewitt, M. Durteste, F. Bremner, M. Lai, L. Miller, A. Saygin, C. Song, P. Keane, A. Schrag, R. Weil (London, United Kingdom)

    Objective: To identify visual measures that relate to higher risk of dementia in Parkinson’s Disease (PD). Background: Dementia affects 50% of people with PD within…
  • 2018 International Congress

    Biomarkers of rapid progression of cognitive decline in Parkinson’s disease

    S. Martinez-Horta, F. Sampedro, J. Pagonabarraga, J. Marin-Lahoz, A. Horta-Barba, H. Bejr-Kasem, I. Aracil, J. Perez-Perez, MA. Boti, J. Kulisevsky. (Barcelona, Spain)

    Objective: We aimed to explore cross-sectional grey-matter volume (GMV) and CSF biomarkers differences in PD patients exhibiting a rapid progression of cognitive decline compared to…
  • 2018 International Congress

    The Parkinson’s Families Project: A family-based study of early onset and familial Parkinson’s disease

    M. Tan, A. Costantini, S. Lubbe, E. Brown, J. Bras, N. Wood, A. Schapira, J. Hardy, H. Morris (London, United Kingdom)

    Objective: The aim of this study is to identify new genetic variants that cause or predispose to Parkinson’s disease (PD). Our secondary aim is to…
  • 2018 International Congress

    The Clinical Research of Parkinson’s Disease with Rapid Eye Movement Sleep Behavior Disorder

    Y. Wang, Z. Liang (Dalian, China)

    Objective: To compare the differences of clinical characteristics between PD patients with rapid eye movement sleep behavior disorder (RBD) (RBD+ group) and those without RBD…
  • 2018 International Congress

    Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

    M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

    Objective: We assessed structural abnormalities of optic radiation (OR) in healthy subjects (HS) and dementia with lewy body (DLB) patients (with visual hallucination) (VH) on…
  • « Previous Page
  • 1
  • …
  • 93
  • 94
  • 95
  • 96
  • 97
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley